Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
暂无分享,去创建一个
Jill S Barnholtz-Sloan | Gad Getz | John N Weinstein | Daniel J Brat | Lynda Chin | Jian Hu | Tom Mikkelsen | Lisa Scarpace | Matthew Meyerson | Eric S Lander | Jonna Grimsby | Carrie Sougnez | Stacey Gabriel | Peter W Laird | Siyuan Zheng | J. Grimsby | S. Gabriel | E. Lander | L. Chin | G. Getz | M. Meyerson | J. Weinstein | Erwin G. Van Meir | D. Brat | T. Mikkelsen | C. Sougnez | R. Verhaak | P. Laird | Selene M. Virk | Hoon Kim | A. Sloan | J. Barnholtz-Sloan | L. Scarpace | F. Muller | Jian Hu | Siyuan Zheng | Mark L. Cohen | Erwin G Van Meir | Roel G W Verhaak | S. Amini | Andrew E Sloan | Hoon Kim | Mark L Cohen | Selene M Virk | Seyed S Amini | Florian Muller | M. Cohen
[1] Obi L. Griffith,et al. SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution , 2014, PLoS Comput. Biol..
[2] J. C. Love,et al. EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing. , 2014, Cancer discovery.
[3] A. Bouchard-Côté,et al. PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.
[4] P. A. Futreal,et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.
[5] Steven J. M. Jones,et al. Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma , 2014, Science.
[6] Noemi Andor,et al. EXPANDS: expanding ploidy and allele frequency on nested subpopulations , 2013, Bioinform..
[7] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[8] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[9] V. Pant,et al. The p53–Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity , 2013, Genes & development.
[10] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[11] Ken Chen,et al. A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. , 2013, Genes & development.
[12] Krishnendu Chatterjee,et al. Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.
[13] Carlos Caldas,et al. The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.
[14] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[15] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[16] Giovanni Parmigiani,et al. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.
[17] A. McKenna,et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.
[18] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[19] Peter J. Campbell,et al. Evolution of the cancer genome , 2012, Nature Reviews Genetics.
[20] Irmtraud M. Meyer,et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.
[21] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[22] M. Adams,et al. Characterizing Mutational Heterogeneity in a Glioblastoma Patient with Double Recurrence , 2012, PloS one.
[23] Lynda Chin,et al. Emerging insights into the molecular and cellular basis of glioblastoma. , 2012, Genes & development.
[24] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[25] Debyani Chakravarty,et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response , 2012, Proceedings of the National Academy of Sciences.
[26] David T. W. Jones,et al. Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.
[27] Joshua F. McMichael,et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.
[28] Rebecca A Betensky,et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. , 2011, Cancer cell.
[29] Paul T. Spellman,et al. Parent-specific copy number in paired tumor-normal studies using circular binary segmentation , 2011, Bioinform..
[30] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[31] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[32] Raymond Sawaya,et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] C. Perou,et al. Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.
[34] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[35] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[36] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[37] Erwin G. Van Meir,et al. Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.
[38] J. Salk. Clonal evolution in cancer , 2010 .
[39] Yuan Qi,et al. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA , IDH 1 , EGFR , and NF 1 Citation Verhaak , 2010 .
[40] Larry Norton,et al. Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.
[41] Terence P. Speed,et al. A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6 , 2009, Bioinform..
[42] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[43] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[44] R. Gilbertson,et al. Making a tumour's bed: glioblastoma stem cells and the vascular niche , 2007, Nature Reviews Cancer.
[45] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[46] Tracy T Batchelor,et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. , 2006, Cancer research.
[47] Marina Konopleva,et al. MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy. , 2005, Blood.
[48] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[49] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[50] M. Nowak,et al. Evolutionary Dynamics of Biological Games , 2004, Science.
[51] R. Solé,et al. Metapopulation dynamics and spatial heterogeneity in cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[52] V. Rotter,et al. The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. , 2002, Carcinogenesis.
[53] Erwin G. Van Meir,et al. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion. , 2002, Cancer research.
[54] Erwin G. Van Meir,et al. Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor , 1999, Oncogene.
[55] F. Cleton. Evolution of Cancer , 1991, British Journal of Cancer.